Successful treatment with adalimumab in infliximab-resistant Crohn's disease

被引:20
作者
Barthel, HR
Gille, T
Halbsguth, A
Kramer, M
机构
关键词
D O I
10.1111/j.1440-1746.2005.03848.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1464 / 1465
页数:2
相关论文
共 7 条
[1]  
Broglia Laura, 2003, Radiol Med, V106, P28
[2]   Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].
Hanauer, SB ;
Feagan, BG ;
Lichtenstein, GR ;
Mayer, LF ;
Schreiber, S ;
Colombel, JF ;
Rachmilewitz, D ;
Wolf, DC ;
Olson, A ;
Bao, WH ;
Rutgeerts, P .
LANCET, 2002, 359 (9317) :1541-1549
[3]   Case reports of heart failure after therapy with a tumor necrosis factor antagonist [J].
Kwon, HJ ;
Coté, TR ;
Cuffe, MS ;
Kramer, JM ;
Braun, MM .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) :807-811
[4]   Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis [J].
Marzo-Ortega, H ;
McGonagle, D ;
O'Connor, P ;
Emery, P .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (01) :74-76
[5]   Safety and efficacy of adalimumab (D2E7) in Crohn's disease patients with an attenuated response to infliximab [J].
Papadakis, KA ;
Shaye, OA ;
Vasiliauskas, EA ;
Ippoliti, A ;
Dubinsky, MC ;
Birt, J ;
Paavola, J ;
Lee, SK ;
Price, J ;
Targan, SR ;
Abreu, MT .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (01) :75-79
[6]   An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease [J].
Sandborn, WJ ;
Hanauer, S ;
Loftus, EV ;
Tremaine, WJ ;
Kane, S ;
Cohen, R ;
Hanson, K ;
Johnson, T ;
Schmitt, D ;
Jeche, R .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (10) :1984-1989
[7]   A pilot study of adalimumab in infliximab-allergic patients [J].
Youdim, A ;
Vasiliauskas, EA ;
Targan, SR ;
Papadakis, KA ;
Ippoliti, A ;
Dubinsky, MC ;
Lechago, J ;
Paavola, J ;
Loane, J ;
Lee, SK ;
Gaiennie, J ;
Smith, K ;
Do, J ;
Abreu, MT .
INFLAMMATORY BOWEL DISEASES, 2004, 10 (04) :333-338